0.0340
0.0000
(0.00%)
As of December 2 at 1:45:39 PM GMT+11. Market Open.
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
29,401.0000
29,401.0000
24,824.0000
20,076.0000
11,073.0000
Cost of Revenue
11,937.0000
11,937.0000
12,204.0000
10,783.0000
5,784.0000
Gross Profit
17,464.0000
17,464.0000
12,620.0000
9,293.0000
5,289.0000
Operating Expense
29,162.0000
29,162.0000
26,213.0000
22,059.0000
20,685.0000
Operating Income
-11,698.0000
-11,698.0000
-13,593.0000
-12,766.0000
-15,396.0000
Net Non Operating Interest Income Expense
-1,267.0000
-1,267.0000
-772.0000
-298.0000
-177.0000
Other Income Expense
-19,092.0000
-19,092.0000
640.0000
940.0000
527.0000
Pretax Income
-32,057.0000
-32,057.0000
-13,725.0000
-12,124.0000
-15,046.0000
Net Income Common Stockholders
-32,057.0000
-32,057.0000
-13,725.0000
-12,124.0000
-15,046.0000
Basic EPS
-0.09
-0.09
-0.04
-0.04
-0.06
Diluted EPS
-0.09
-0.09
-0.04
-0.04
-0.06
Basic Average Shares
375,893.7650
375,893.7650
351,049.9150
304,159.0650
248,681.8080
Diluted Average Shares
375,893.7650
375,893.7650
351,049.9150
304,159.0650
248,681.8080
Net Income from Continuing & Discontinued Operation
-32,057.0000
-32,057.0000
-13,725.0000
-12,124.0000
-15,046.0000
Normalized Income
-14,266.0000
-14,266.0000
-13,725.0000
-11,958.0000
-15,046.0000
Interest Income
8.0000
8.0000
36.0000
5.0000
8.0000
Interest Expense
911.0000
911.0000
605.0000
61.0000
2.0000
Net Interest Income
-1,267.0000
-1,267.0000
-772.0000
-298.0000
-177.0000
EBIT
-31,146.0000
-31,146.0000
-13,120.0000
-12,063.0000
-15,044.0000
EBITDA
-28,925.0000
-28,925.0000
-10,437.0000
-9,316.0000
-13,030.0000
Reconciled Cost of Revenue
11,937.0000
11,937.0000
12,204.0000
10,783.0000
5,784.0000
Reconciled Depreciation
2,221.0000
2,221.0000
2,683.0000
2,747.0000
2,014.0000
Net Income from Continuing Operation Net Minority Interest
-32,057.0000
-32,057.0000
-13,725.0000
-12,124.0000
-15,046.0000
Total Unusual Items Excluding Goodwill
-17,791.0000
-17,791.0000
--
-166.0000
--
Total Unusual Items
-17,791.0000
-17,791.0000
--
-166.0000
--
Normalized EBITDA
-11,134.0000
-11,134.0000
-10,437.0000
-9,150.0000
-13,030.0000
6/30/2021 - 9/21/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AFP.AX AFT Pharmaceuticals Limited
2.4900
-3.49%
EOF.AX Ecofibre Limited
0.0300
-3.23%
EPN.AX Epsilon Healthcare Limited
0.0240
0.00%
BOD.AX Bod Science Limited
0.0240
0.00%
BP8.AX BPH Global Ltd
0.0020
0.00%
ECS.AX ECS Botanics Holdings Ltd
0.0140
-6.67%
CAN.AX Cann Group Limited
0.0350
-2.78%
EXL.AX Elixinol Wellness Limited
0.0400
-6.98%